Business Description
Armata Pharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US03211P3010
Description
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | -0.33 | |||||
| Debt-to-Equity | -3.75 | |||||
| Debt-to-EBITDA | -1.76 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -13.4 | |||||
| 3-Year EPS without NRI Growth Rate | -10.1 | |||||
| 3-Year FCF Growth Rate | -9.8 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.12 | |||||
| 9-Day RSI | 36.69 | |||||
| 14-Day RSI | 37.25 | |||||
| 6-1 Month Momentum % | 75.73 | |||||
| 12-1 Month Momentum % | 153.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.16 | |||||
| Quick Ratio | 1.16 | |||||
| Cash Ratio | 0.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.6 | |||||
| Shareholder Yield % | -58.04 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -1039.24 | |||||
| ROA % | -66.78 | |||||
| ROIC % | -40.73 | |||||
| ROC (Joel Greenblatt) % | -130.81 | |||||
| ROCE % | -98.87 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.87 | |||||
| EV-to-Forward-EBIT | -4.22 | |||||
| EV-to-EBITDA | -2.91 | |||||
| EV-to-Forward-EBITDA | -4.22 | |||||
| EV-to-Forward-Revenue | 41.46 | |||||
| EV-to-FCF | -3.58 | |||||
| Earnings Yield (Greenblatt) % | -34.84 | |||||
| FCF Yield % | -60.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Armata Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.841 | ||
| Beta | 2.73 | ||
| Volatility % | 139.83 | ||
| 14-Day RSI | 37.25 | ||
| 14-Day ATR (€) | 0.139971 | ||
| 20-Day SMA (€) | 2.819 | ||
| 12-1 Month Momentum % | 153.15 | ||
| 52-Week Range (€) | 0.925 - 4.46 | ||
| Shares Outstanding (Mil) | 36.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Armata Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Armata Pharmaceuticals Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Armata Pharmaceuticals Inc Frequently Asked Questions
What is Armata Pharmaceuticals Inc(FRA:TG1N)'s stock price today?
The current price of FRA:TG1N is €2.38. The 52 week high of FRA:TG1N is €4.46 and 52 week low is €0.93.
When is next earnings date of Armata Pharmaceuticals Inc(FRA:TG1N)?
The next earnings date of Armata Pharmaceuticals Inc(FRA:TG1N) is 2024-05-10 Est..
Does Armata Pharmaceuticals Inc(FRA:TG1N) pay dividends? If so, how much?
Armata Pharmaceuticals Inc(FRA:TG1N) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers